Professionalization and Internationalization - Sinopep in DCAT 2025 in New York

The premiere gathering of heavy hitters within the global bio/pharmaceutical industry, the 2025 DCAT saw Mr Tong Ziquan (Chairman) and Mr Li Xiaohua (Sr. VP) leading the BD team to participate in this grand event.

Throughout the sessions, Sinopep met and discussed the collaborations with the global business partners and customers, paving the way for continued success. In September 2024, Sinopep successfully passed the FDA’s unnoticed cGMP inspection, which earned the customers’ recognition for the excellent quality operations. 

Sinopep remains committed to its platform strategy and continuously enhancing the professionalism to provide the best possible values to its customers, partners and the society.